Page last updated: 2024-08-18

soman and Absence Status

soman has been researched along with Absence Status in 48 studies

Research

Studies (48)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (10.42)	18.2507
2000's	7 (14.58)	29.6817
2010's	23 (47.92)	24.3611
2020's	13 (27.08)	2.80

Authors

Authors	Studies
Gage, M; Kannurpatti, SS; Meyer, CM; Rao, NS; Thedens, DR; Thippeswamy, T; Vasanthi, SS	1
Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Figueiredo, TH; Rossetti, K	1
Almanza, A; Bryant, E; Carlo, AM; Corson, BE; Gage, M; Kharate, M; Mafuta, C; Massey, N; Meyer, C; Ostrander, M; Rao, NS; Samidurai, M; Showman, L; Thippeswamy, T; Trevino, L; Vasanthi, SS; Wachter, L; Wang, C; Wohlgemuth, M	1
Baldwin, R; Estrada, IBF; Furtado, MA; Lumley, L; Naylor, D; Niquet, J; Rossetti, F; Schultz, M; Suchomelova, L; Wasterlain, CG	1
de Araujo Furtado, M; Kundrick, E; Lee-Stubbs, RB; Lumley, LA; Marrero-Rosado, B; Schultz, C; Stone, M; Walker, K	1
Ardinger, CE; Beske, PH; Bodner, PM; Dubée, PB; Dunn, EN; Eisen, MR; Haines, KM; Honnold, CL; McCarren, HS; McDonough, JH; McNutt, PM; Nguyen, DL; Ondeck, CA; Santoro, AN	1
Apland, JP; Aroniadou-Anderjaska, V; Braga, MFM; De Araujo Furtado, M; Figueiredo, TH	1
de Araujo Furtado, M; Kundrick, ER; Lumley, LA; Marrero-Rosado, BM; Nguyen, DA; Schultz, CR; Stone, MF; Walker, KA	1
Abreu-Melon, J; Dingledine, R; McCarren, HS; McDonough, JH; Rojas, A; Wang, J; Wang, S; Wang, W	1
He, H; Lin, G; Long, J; Luo, Y; Sui, X; Wang, Q; Wang, S; Wang, Y; Yang, J	1
Acon-Chen, C; Loughery, TN; Shih, TM; Whitten, KA	1
Kuruba, R; Reddy, DS; Wu, X; Zaayman, M	1
Chandler, JK; Ferrara-Bowens, TM; Guignet, MA; Irwin, JF; Johnson, EA; Laitipaya, K; McCabe, JT; Palmer, DD; Shumway, LJ; Tucker, LB; Wegner, MD	1
Apland, JP; Aroniadou-Anderjaska, V; Braga, MFM; Figueiredo, TH; Pidoplichko, VI; Rossetti, K	1
Lee, RB; Lumley, LA; Marrero-Rosado, B; Moffett, MC; Rice, MW; Rossetti, F; Stone, MF	1
de Araujo Furtado, M; Du, F; Kundrick, E; Lumley, LA; Marrero-Rosado, B; O'Brien, S; Schultz, CR; Stone, M; Walker, K	1
Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Figueiredo, TH	1
Almeida-Suhett, CP; Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Figueiredo, TH; Prager, EM	1
Bialer, M; Finnell, RH; Hen, N; McDonough, JH; Shekh-Ahmad, T; Wlodarczyk, B; Yagen, B	1
Almeida-Suhett, CP; Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Figueiredo, TH; Olsen, CH; Prager, EM; Rossetti, F	1
Chen, C; Chen, J; Greig, NH; He, J; Iskandar, K; Jacobowitz, DM; Marini, AM; McDonough, JH; Pan, H; Piermartiri, T; Wu, W; Yu, QS	1
Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Pidoplichko, VI; Prager, EM	1
Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Figueiredo, TH; Miller, SL; Rossetti, F	1
Almeida-Suhett, CP; Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Figueiredo, TH; Miller, SL; Prager, EM	1
Apland, JP; Chen, J; Grunberg, N; Marini, AM; McDonough, J; Pan, H; Piermartiri, TC	1
Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Figueiredo, TH; Krishnan, JK; Miller, SL; Pidoplichko, VI	1
Carpentier, P; Dorandeu, F; Fauvelle, F; Foquin, A; Graveron-Demilly, D; Rabeson, H; Testylier, G; van Ormondt, D	1
Arvers, P; Carpentier, P; Dorandeu, F; Fauvelle, F; Foquin, A; Graveron-Demilly, D; Rabeson, H; Testylier, G	1
de Araujo Furtado, M; Lichtenstein, S; Lumley, LA; Robison, C; Tong, LC; Yourick, DL	1
Campbell, AJ; Clarkson, ED; Demar, JC; Evans, SA; Gordon, RK; Herdman, CA; Khan, FA; Ku, TC; Leader, H; Marek, E; Medynets, MA; Nambiar, MP; Owens, RR; Ratcliffe, RH; Schulz, SM; Thangavelu, SG	1
Johnson, EA; Kan, RK	1
Ling, EA; Loke, WK; Tang, FR	1
Dao, TL; Geddes, CE; Guignet, MA; Johnson, EA; Kan, RK; Koemeter-Cox, AI	1
Carpentier, P; Dorandeu, F; Foquin, A	1
Baille, V; Barbier, L; Beaup, C; Carpentier, P; Dhote, F; Dorandeu, F; Foquin, A; Peinnequin, A; Pernot, F; Testylier, G	1
Carpentier, P; Dorandeu, F; Fauvelle, F; Foquin, A; Testylier, G	1
Barbier, L; Carpentier, P; Dhote, F; Dorandeu, F; Testylier, G	1
Adams, JD; Cross, R; Klaidman, LK; Pazdernik, TL; Samson, F	1
Benjamin, A; McDonough, JH; McMonagle, JD; Rowland, T; Shih, TM	1
Bhagat, YA; Hamilton, MG; Kendall, EJ; Mikler, J; Obenaus, A	1
Baubichon, D; Bernabé, D; Burckhart, MF; Carpentier, P; Dorandeu, F; Four, E; Lallement, G	1
Gordon, RK; Nambiar, MP; Ratcliffe, RH; Rezk, PE; Steele, KE; Tetz, LM	1
Baille, V; Carpentier, P; Dorandeu, F; Lallement, G; Mikler, J; Sawyer, T; Testylier, G	1
Blanchet, G; Carpentier, P; Lallement, G; Sentenac-Roumanou, H	1
Beers, ET; Brennecke, LH; Sparenborg, S	1
Koplovitz, I; Skvorak, JP	1
Ballough, GP; Cann, FJ; Filbert, MG; Forster, JS; Kling, CE; Smith, CD	1
Braitman, DJ; Brennecke, LH; Jaax, NK; Sparenborg, S	1

Reviews

4 review(s) available for soman and Absence Status

Article	Year
Rational polytherapy in the treatment of cholinergic seizures. Neurobiology of disease, 2020, Volume: 133 Topics: Animals; Anticonvulsants; Cholinesterase Inhibitors; Drug Therapy, Combination; Ketamine; Male; Midazolam; Muscarinic Agonists; Nerve Agents; Pilocarpine; Rats; Rats, Sprague-Dawley; Soman; Status Epilepticus; Valproic Acid	2020
Targeting the glutamatergic system to counteract organophosphate poisoning: A novel therapeutic strategy. Neurobiology of disease, 2020, Volume: 133 Topics: Animals; Anticonvulsants; Cholinesterase Inhibitors; Humans; Isoquinolines; Nerve Agents; Neuroprotective Agents; Organophosphate Poisoning; Rats; Receptors, AMPA; Receptors, Kainic Acid; Soman; Status Epilepticus; Tetrazoles	2020
Comparison of status epilepticus models induced by pilocarpine and nerve agents - a systematic review of the underlying aetiology and adopted therapeutic approaches. Current medicinal chemistry, 2011, Volume: 18, Issue:6 Topics: Animals; Brain; Chemical Warfare Agents; Humans; Pilocarpine; Sarin; Soman; Status Epilepticus	2011
Ketamine combinations for the field treatment of soman-induced self-sustaining status epilepticus. Review of current data and perspectives. Chemico-biological interactions, 2013, Mar-25, Volume: 203, Issue:1 Topics: Animals; Brain; Chemical Warfare Agents; Cholinesterase Inhibitors; Dizocilpine Maleate; Guinea Pigs; Humans; Ketamine; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Soman; Status Epilepticus; Time Factors	2013

Other Studies

44 other study(ies) available for soman and Absence Status

Article	Year
Sex-based structural and functional MRI outcomes in the rat brain after soman (GD) exposure-induced status epilepticus. Epilepsia open, 2023, Volume: 8, Issue:2 Topics: Animals; Brain; Female; Humans; Magnetic Resonance Imaging; Male; Nerve Agents; Rats; Rats, Sprague-Dawley; Soman; Status Epilepticus	2023
Delayed tezampanel and caramiphen treatment but not midazolam protects against long-term neuropathology after soman exposure. Experimental biology and medicine (Maywood, N.J.), 2023, Volume: 248, Issue:7 Topics: Animals; Anticonvulsants; Brain; Brain Injuries; Female; Male; Midazolam; Nerve Agents; Rats; Seizures; Soman; Status Epilepticus	2023
Disease-modifying effects of a glial-targeted inducible nitric oxide synthase inhibitor (1400W) in mixed-sex cohorts of a rat soman (GD) model of epilepsy. Journal of neuroinflammation, 2023, Jul-12, Volume: 20, Issue:1 Topics: Animals; Atropine; Cytokines; Enzyme Inhibitors; Epilepsy; Gliosis; Male; Midazolam; Neuroglia; Nitric Oxide Synthase Type II; Parvalbumins; Rats; Rats, Sprague-Dawley; Seizures; Soman; Status Epilepticus	2023
Delayed midazolam dose effects against soman in male and female plasma carboxylesterase knockout mice. Annals of the New York Academy of Sciences, 2020, Volume: 1479, Issue:1 Topics: Animals; Carboxylesterase; Dose-Response Relationship, Drug; Female; Male; Mice; Mice, Knockout; Midazolam; Nerve Agents; Sex Characteristics; Soman; Status Epilepticus	2020
Characterization and treatment of spontaneous recurrent seizures following nerve agent-induced status epilepticus in mice. Epilepsy research, 2020, Volume: 162 Topics: Animals; Anticonvulsants; Disease Models, Animal; Levetiracetam; Mice; Nerve Agents; Phenobarbital; Soman; Status Epilepticus; Valproic Acid	2020
Electroencephalographic analysis in soman-exposed 21-day-old rats and the effects of midazolam or LY293558 with caramiphen. Annals of the New York Academy of Sciences, 2020, Volume: 1479, Issue:1 Topics: Animals; Antidotes; Cyclopentanes; Electrocardiography; Isoquinolines; Male; Midazolam; Nerve Agents; Rats; Rats, Sprague-Dawley; Soman; Status Epilepticus; Tetrazoles	2020
Ketamine as adjunct to midazolam treatment following soman-induced status epilepticus reduces seizure severity, epileptogenesis, and brain pathology in plasma carboxylesterase knockout mice. Epilepsy & behavior : E&B, 2020, Volume: 111 Topics: Animals; Anticonvulsants; Brain; Carboxylesterase; Drug Therapy, Combination; Electroencephalography; Female; Ketamine; Male; Mice; Mice, Knockout; Midazolam; Seizures; Soman; Status Epilepticus	2020
Comparison of neuropathology in rats following status epilepticus induced by diisopropylfluorophosphate and soman. Neurotoxicology, 2021, Volume: 83 Topics: Animals; Blood-Brain Barrier; Brain; Brain Waves; Cell Death; Cyclooxygenase 2; Disease Models, Animal; Electroencephalography; Encephalitis; Gliosis; Isoflurophate; Male; Rats, Sprague-Dawley; Soman; Status Epilepticus; Time Factors; Weight Loss	2021
TRPV4 Regulates Soman-Induced Status Epilepticus and Secondary Brain Injury via NMDA Receptor and NLRP3 Inflammasome. Neuroscience bulletin, 2021, Volume: 37, Issue:7 Topics: Animals; Brain; Brain Injuries; Inflammasomes; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Receptors, N-Methyl-D-Aspartate; Soman; Status Epilepticus; TRPV Cation Channels	2021
Intramuscularly administered A1 adenosine receptor agonists as delayed treatment for organophosphorus nerve agent-induced Status Epilepticus. Toxicology and applied pharmacology, 2021, 05-15, Volume: 419 Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Anticonvulsants; Brain; Deoxyadenosines; Disease Models, Animal; Drug Administration Schedule; Injections, Intramuscular; Male; Neuroprotective Agents; Norbornanes; Rats, Sprague-Dawley; Sarin; Soman; Status Epilepticus; Time Factors	2021
Comparative profile of refractory status epilepticus models following exposure of cholinergic agents pilocarpine, DFP, and soman. Neuropharmacology, 2021, 06-15, Volume: 191 Topics: Animals; Anticonvulsants; Brain; Brain Injuries; Diazepam; Hippocampus; Isoflurophate; Male; Neurons; Organophosphates; Pilocarpine; Rats; Rats, Sprague-Dawley; Soman; Status Epilepticus	2021
Neuropathological and behavioral sequelae in IL-1R1 and IL-1Ra gene knockout mice after soman (GD) exposure. Neurotoxicology, 2017, Volume: 63 Topics: Animals; Brain; Convulsants; Disease Models, Animal; Exploratory Behavior; Gene Expression Regulation; Interleukin 1 Receptor Antagonist Protein; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Interleukin-1 Type I; Signal Transduction; Soman; Spatial Learning; Status Epilepticus	2017
Comparing the Antiseizure and Neuroprotective Efficacy of LY293558, Diazepam, Caramiphen, and LY293558-Caramiphen Combination against Soman in a Rat Model Relevant to the Pediatric Population. The Journal of pharmacology and experimental therapeutics, 2018, Volume: 365, Issue:2 Topics: Animals; Anticonvulsants; Anxiety; Basolateral Nuclear Complex; Behavior, Animal; Child; Cyclopentanes; Diazepam; Disease Models, Animal; Drug Interactions; Humans; Isoquinolines; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Soman; Status Epilepticus; Tetrazoles	2018
Age-Related Susceptibility to Epileptogenesis and Neuronal Loss in Male Fischer Rats Exposed to Soman and Treated With Medical Countermeasures. Toxicological sciences : an official journal of the Society of Toxicology, 2018, 07-01, Volume: 164, Issue:1 Topics: Aging; Animals; Anticonvulsants; Behavior, Animal; Brain; Cell Count; Chemical Warfare Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Lethal Dose 50; Male; Medical Countermeasures; Neurons; Rats, Inbred F344; Seizures; Soman; Status Epilepticus; Telemetry; Time Factors	2018
Soman-induced status epilepticus, epileptogenesis, and neuropathology in carboxylesterase knockout mice treated with midazolam. Epilepsia, 2018, Volume: 59, Issue:12 Topics: Animals; Anticonvulsants; Carboxylesterase; Cell Count; Chemical Warfare Agents; Cholinesterase Reactivators; Electroencephalography; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Midazolam; Nerve Degeneration; Seizures; Soman; Status Epilepticus	2018
Acetylcholinesterase inhibition in the basolateral amygdala plays a key role in the induction of status epilepticus after soman exposure. Neurotoxicology, 2013, Volume: 38 Topics: Amygdala; Animals; Brain; Cholinesterase Inhibitors; Hippocampus; Male; Nerve Degeneration; Olfactory Pathways; Rats; Soman; Status Epilepticus	2013
Stereoselective pharmacodynamic and pharmacokinetic analysis of sec-Butylpropylacetamide (SPD), a new CNS-active derivative of valproic acid with unique activity against status epilepticus. Journal of medicinal chemistry, 2013, Aug-22, Volume: 56, Issue:16 Topics: Acetamides; Amides; Animals; Anticonvulsants; Disease Models, Animal; Rats; Soman; Status Epilepticus; Stereoisomerism; Teratogens; Valproic Acid	2013
The recovery of acetylcholinesterase activity and the progression of neuropathological and pathophysiological alterations in the rat basolateral amygdala after soman-induced status epilepticus: relation to anxiety-like behavior. Neuropharmacology, 2014, Volume: 81 Topics: Acetylcholinesterase; Animals; Anxiety; Basolateral Nuclear Complex; Cholinesterase Inhibitors; Disease Models, Animal; Disease Progression; Exploratory Behavior; Fluoresceins; Gene Expression Regulation, Enzymologic; Glutamate Decarboxylase; Long-Term Potentiation; Male; Rats; Rats, Sprague-Dawley; Recovery of Function; Reflex, Startle; Soman; Status Epilepticus; Time Factors	2014
(-)-Phenserine attenuates soman-induced neuropathology. PloS one, 2014, Volume: 9, Issue:6 Topics: Animals; Carrier Proteins; Chemical Warfare Agents; Cholinesterase Inhibitors; Gene Expression Regulation; Homer Scaffolding Proteins; Male; Physostigmine; Rats; Rats, Sprague-Dawley; Soman; Status Epilepticus	2014
Pathophysiological mechanisms underlying increased anxiety after soman exposure: reduced GABAergic inhibition in the basolateral amygdala. Neurotoxicology, 2014, Volume: 44 Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Anxiety; Basolateral Nuclear Complex; Chemical Warfare Agents; Inhibitory Postsynaptic Potentials; Male; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Soman; Status Epilepticus; Synaptic Transmission	2014
The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: comparison with UBP302. The Journal of pharmacology and experimental therapeutics, 2014, Volume: 351, Issue:2 Topics: Alanine; Amygdala; Animals; Anticonvulsants; Anxiety; Diazepam; Hippocampus; Male; Nerve Degeneration; Rats; Rats, Sprague-Dawley; Receptors, Kainic Acid; Seizures; Soman; Status Epilepticus; Thymine	2014
A rat model of nerve agent exposure applicable to the pediatric population: The anticonvulsant efficacies of atropine and GluK1 antagonists. Toxicology and applied pharmacology, 2015, Apr-15, Volume: 284, Issue:2 Topics: Acetylcholinesterase; Animals; Anticonvulsants; Atropine; Chemical Warfare Agents; Cholinesterase Inhibitors; Disease Models, Animal; Hippocampus; Isoquinolines; Male; Nerve Degeneration; Oximes; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Kainic Acid; Seizures; Soman; Status Epilepticus; Tetrazoles	2015
Alpha-Linolenic Acid-Induced Increase in Neurogenesis is a Key Factor in the Improvement in the Passive Avoidance Task After Soman Exposure. Neuromolecular medicine, 2015, Volume: 17, Issue:3 Topics: alpha-Linolenic Acid; Animals; Antigens, Nuclear; Atropine Derivatives; Avoidance Learning; Brain Damage, Chronic; Brain-Derived Neurotrophic Factor; Diazepam; DNA Replication; Doublecortin Domain Proteins; Electroshock; Exploratory Behavior; Hippocampus; Male; Mechanistic Target of Rapamycin Complex 1; Microtubule-Associated Proteins; Multiprotein Complexes; Nerve Tissue Proteins; Neurogenesis; Neuropeptides; Neuroprotective Agents; Neurotoxins; Oximes; Proto-Oncogene Proteins c-akt; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Receptor, trkB; Signal Transduction; Sirolimus; Soman; Status Epilepticus; TOR Serine-Threonine Kinases	2015
The M1 Muscarinic Receptor Antagonist VU0255035 Delays the Development of Status Epilepticus after Organophosphate Exposure and Prevents Hyperexcitability in the Basolateral Amygdala. The Journal of pharmacology and experimental therapeutics, 2017, Volume: 360, Issue:1 Topics: Animals; Basolateral Nuclear Complex; Male; Paraoxon; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Soman; Status Epilepticus; Sulfonamides; Synapses; Thiadiazoles	2017
Quantitation with QUEST of brain HRMAS-NMR signals: application to metabolic disorders in experimental epileptic seizures. Magnetic resonance in medicine, 2008, Volume: 59, Issue:6 Topics: Acetates; Alanine; Algorithms; Animals; Aspartic Acid; Brain; Choline; gamma-Aminobutyric Acid; Glutamine; Inositol; Lactates; Magnetic Resonance Spectroscopy; Mice; Monte Carlo Method; Soman; Status Epilepticus	2008
Changes in mouse brain metabolism following a convulsive dose of soman: a proton HRMAS NMR study. Toxicology, 2010, Jan-12, Volume: 267, Issue:1-3 Topics: Animals; Brain; Cholinesterase Inhibitors; Disease Models, Animal; Magnetic Resonance Imaging; Male; Mice; Protons; Soman; Status Epilepticus	2010
Spontaneous recurrent seizures after status epilepticus induced by soman in Sprague-Dawley rats. Epilepsia, 2010, Volume: 51, Issue:8 Topics: Animals; Cholinesterase Inhibitors; Disease Models, Animal; Electroencephalography; Hippocampus; Male; Neurologic Examination; Rats; Rats, Sprague-Dawley; Recurrence; Silver Staining; Soman; Status Epilepticus; Telemetry; Thalamus	2010
Pro-2-PAM therapy for central and peripheral cholinesterases. Chemico-biological interactions, 2010, Sep-06, Volume: 187, Issue:1-3 Topics: Acetylcholinesterase; Animals; Apoptosis; Brain; Central Nervous System; Cholinesterase Reactivators; Dose-Response Relationship, Drug; Electroencephalography; Enzyme Activation; Guinea Pigs; Hippocampus; Isoflurophate; Male; Neurons; Peripheral Nervous System; Pralidoxime Compounds; Prodrugs; Skin; Soman; Status Epilepticus; Survival Analysis	2010
The acute phase response and soman-induced status epilepticus: temporal, regional and cellular changes in rat brain cytokine concentrations. Journal of neuroinflammation, 2010, Jul-22, Volume: 7 Topics: Acute-Phase Reaction; Animals; Brain; Convulsants; Cytokines; Humans; Immunoassay; Interleukin-1beta; Interleukin-6; Male; Rats; Rats, Sprague-Dawley; Soman; Status Epilepticus; Tumor Necrosis Factor-alpha	2010
Increased expression of the chemokines CXCL1 and MIP-1α by resident brain cells precedes neutrophil infiltration in the brain following prolonged soman-induced status epilepticus in rats. Journal of neuroinflammation, 2011, May-02, Volume: 8 Topics: Animals; Brain; Chemokine CCL3; Chemokine CXCL1; Convulsants; Endothelial Cells; Immunoassay; Male; Microglia; Neurons; Neutrophil Infiltration; Rats; Rats, Sprague-Dawley; Soman; Status Epilepticus	2011
A new use for an old method: the Woelcke myelin stain for counting degenerating neurons in the brain of mice following status epilepticus. Neurotoxicology, 2012, Volume: 33, Issue:4 Topics: Animals; Biomarkers; Brain; Cell Count; Coloring Agents; Disease Models, Animal; Eosine I Bluish; Hematoxylin; Image Processing, Computer-Assisted; Male; Mice; Myelin Sheath; Nerve Degeneration; Neurons; Soman; Staining and Labeling; Status Epilepticus; Time Factors	2012
Combinations of ketamine and atropine are neuroprotective and reduce neuroinflammation after a toxic status epilepticus in mice. Toxicology and applied pharmacology, 2012, Mar-01, Volume: 259, Issue:2 Topics: Animals; Area Under Curve; Atropine; Brain; Chemical Warfare Agents; Chemokine CCL5; Chemokine CXCL1; Excitatory Amino Acid Antagonists; Ketamine; Male; Mice; Muscarinic Antagonists; Neuroglia; Neutrophils; Polymerase Chain Reaction; Random Allocation; RNA, Messenger; Soman; Status Epilepticus	2012
Prediction of neuroprotective treatment efficiency using a HRMAS NMR-based statistical model of refractory status epilepticus on mouse: a metabolomic approach supported by histology. Journal of proteome research, 2012, Jul-06, Volume: 11, Issue:7 Topics: Animals; Anticonvulsants; Atropine; Biomarkers; Brain; Drug Therapy, Combination; Ketamine; Magnetic Resonance Spectroscopy; Male; Metabolome; Mice; Midazolam; Multivariate Analysis; Neuroprotective Agents; Principal Component Analysis; Soman; Status Epilepticus	2012
Alterations in brain glutathione homeostasis induced by the nerve gas soman. Neurotoxicity research, 2003, Volume: 5, Issue:3 Topics: Animals; Brain; Chemical Warfare Agents; Glutathione; Homeostasis; Male; Nerve Tissue Proteins; Rats; Rats, Wistar; Soman; Status Epilepticus; Sulfhydryl Compounds; Time Factors	2003
Effects of fosphenytoin on nerve agent-induced status epilepticus. Drug and chemical toxicology, 2004, Volume: 27, Issue:1 Topics: Animals; Anticonvulsants; Atropine; Chemical Warfare Agents; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroencephalography; Guinea Pigs; Injections, Intraperitoneal; Male; Phenytoin; Pralidoxime Compounds; Pyridostigmine Bromide; Soman; Status Epilepticus	2004
Neuroprotection from soman-induced seizures in the rodent: evaluation with diffusion- and T2-weighted magnetic resonance imaging. Neurotoxicology, 2005, Volume: 26, Issue:6 Topics: Animals; Anticonvulsants; Brain; Cell Death; Cyclohexanes; Cyclohexenes; Diazepam; Diffusion Magnetic Resonance Imaging; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Piperidines; Rats; Rats, Sprague-Dawley; Seizures; Soman; Status Epilepticus	2005
Efficacy of the ketamine-atropine combination in the delayed treatment of soman-induced status epilepticus. Brain research, 2005, Jul-27, Volume: 1051, Issue:1-2 Topics: Animals; Anticonvulsants; Atropine; Chemical Warfare Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electroencephalography; Guinea Pigs; Ketamine; Male; Midazolam; Seizures; Soman; Statistics, Nonparametric; Status Epilepticus; Time Factors	2005
Development of a rat pilocarpine model of seizure/status epilepticus that mimics chemical warfare nerve agent exposure. Toxicology and industrial health, 2006, Volume: 22, Issue:6 Topics: Animals; Anticonvulsants; Behavior, Animal; Body Temperature; Brain; Chemical Warfare Agents; Cholinergic Antagonists; Drug Evaluation, Preclinical; Electroencephalography; Heart Rate; Lethal Dose 50; Lithium Chloride; Male; Models, Animal; Motor Activity; Muscarinic Agonists; N-Methylscopolamine; Neuroprotective Agents; Neurotoxicity Syndromes; Pilocarpine; Rats; Rats, Sprague-Dawley; Seizures; Soman; Status Epilepticus	2006
Protective effects of S+ ketamine and atropine against lethality and brain damage during soman-induced status epilepticus in guinea-pigs. Toxicology, 2007, May-20, Volume: 234, Issue:3 Topics: Animals; Atropine; Brain Damage, Chronic; Cholinesterase Inhibitors; Excitatory Amino Acid Antagonists; Guinea Pigs; Ketamine; Lethal Dose 50; Male; Muscarinic Antagonists; Oximes; Pyridinium Compounds; Soman; Status Epilepticus; Stereoisomerism	2007
[Prevention and treatment of status epilepticus induced by soman]. Annales pharmaceutiques francaises, 1994, Volume: 52, Issue:1 Topics: Animals; Diazepam; Guinea Pigs; Male; Phencyclidine; Rats; Rats, Wistar; Soman; Status Epilepticus	1994
Pharmacological dissociation of the motor and electrical aspects of convulsive status epilepticus induced by the cholinesterase inhibitor soman. Epilepsy research, 1993, Volume: 14, Issue:2 Topics: Analysis of Variance; Animals; Antidotes; Atropine; Brain; Cholinesterase Inhibitors; Diazepam; Electroencephalography; Guinea Pigs; Image Processing, Computer-Assisted; Male; Pralidoxime Compounds; Pyridostigmine Bromide; Scopolamine; Soman; Status Epilepticus	1993
Electrocorticographic changes during generalized convulsive status epilepticus in soman intoxicated rats. Epilepsy research, 1998, Volume: 30, Issue:2 Topics: Animals; Cholinesterase Reactivators; Convulsants; Electroencephalography; Male; Oximes; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Soman; Status Epilepticus	1998
GM1 monosialoganglioside pretreatment protects against soman-induced seizure-related brain damage. Molecular and chemical neuropathology, 1998, Volume: 34, Issue:1 Topics: Acetylcholinesterase; Animals; Brain; Brain Chemistry; Brain Damage, Chronic; Cholinesterase Inhibitors; Convulsants; Electroencephalography; G(M1) Ganglioside; Glial Fibrillary Acidic Protein; Image Processing, Computer-Assisted; Injections, Intraventricular; Male; Microtubule-Associated Proteins; Nerve Tissue Proteins; Neuroprotective Agents; Neurotoxins; Rats; Rats, Sprague-Dawley; Seizures; Soman; Status Epilepticus	1998
Dizocilpine (MK-801) arrests status epilepticus and prevents brain damage induced by soman. Neuropharmacology, 1992, Volume: 31, Issue:4 Topics: Amygdala; Animals; Brain; Cerebral Cortex; Dizocilpine Maleate; Electroencephalography; Evoked Potentials; Guinea Pigs; Hippocampus; Necrosis; Neurons; Organ Specificity; Soman; Status Epilepticus; Thalamus; Time Factors	1992